← Browse by Condition
Medical Condition
pyoderma gangrenosum
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 2
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argen...
Sponsor
Boehringer Ingelheim
NCT06563323 Phase 2
Recruiting
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Enrollment
17 pts
Location
United States
Sponsor
Oregon Health and Science Univ...